| molecular function |
|---|
| | GO:0031701 | | angiotensin receptor binding | | Interacting selectively and non-covalently with an angiotensin receptor. |
| | GO:0005179 | | hormone activity | | The action characteristic of a hormone, any substance formed in very small amounts in one specialized organ or group of cells and carried (sometimes in the bloodstream) to another organ or group of cells in the same organism, upon which it has a specific regulatory action. The term was originally applied to agents with a stimulatory physiological action in vertebrate animals (as opposed to a chalone, which has a depressant action). Usage is now extended to regulatory compounds in lower animals and plants, and to synthetic substances having comparable effects; all bind receptors and trigger some biological process. |
| | GO:0048018 | | receptor agonist activity | | Interacts with receptors such that the proportion of receptors in the active form is increased. |
| | GO:0004867 | | serine-type endopeptidase inhibitor activity | | Stops, prevents or reduces the activity of serine-type endopeptidases, enzymes that catalyze the hydrolysis of nonterminal peptide bonds in a polypeptide chain; a serine residue (and a histidine residue) are at the active center of the enzyme. |
| | GO:0017080 | | sodium channel regulator activity | | Modulates the activity of a sodium channel. |
| | GO:0031702 | | type 1 angiotensin receptor binding | | Interacting selectively and non-covalently with a type 1 angiotensin receptor. |
| | GO:0031703 | | type 2 angiotensin receptor binding | | Interacting selectively and non-covalently with a type 2 angiotensin receptor. |
| biological process |
|---|
| | GO:0070371 | | ERK1 and ERK2 cascade | | An intracellular protein kinase cascade containing at least ERK1 or ERK2 (MAPKs), a MEK (a MAPKK) and a MAP3K. The cascade can also contain two additional tiers: the upstream MAP4K and the downstream MAP Kinase-activated kinase (MAPKAPK). The kinases in each tier phosphorylate and activate the kinases in the downstream tier to transmit a signal within a cell. |
| | GO:0007186 | | G-protein coupled receptor signaling pathway | | A series of molecular signals that proceeds with an activated receptor promoting the exchange of GDP for GTP on the alpha-subunit of an associated heterotrimeric G-protein complex. The GTP-bound activated alpha-G-protein then dissociates from the beta- and gamma-subunits to further transmit the signal within the cell. The pathway begins with receptor-ligand interaction, or for basal GPCR signaling the pathway begins with the receptor activating its G protein in the absence of an agonist, and ends with regulation of a downstream cellular process, e.g. transcription. The pathway can start from the plasma membrane, Golgi or nuclear membrane (PMID:24568158 and PMID:16902576). |
| | GO:0007202 | | activation of phospholipase C activity | | The initiation of the activity of the inactive enzyme phospolipase C as the result of a series of molecular signals generated as a consequence of a G-protein coupled receptor binding to its physiological ligand. |
| | GO:0007568 | | aging | | A developmental process that is a deterioration and loss of function over time. Aging includes loss of functions such as resistance to disease, homeostasis, and fertility, as well as wear and tear. Aging includes cellular senescence, but is more inclusive. May precede death and may succeed developmental maturation (GO:0021700). |
| | GO:0038166 | | angiotensin-activated signaling pathway | | The series of molecular signals generated as a consequence of angiotensin II binding to an angiotensin receptor on the surface of the cell, and proceeding with the activated receptor transmitting the signal to a heterotrimeric G-protein complex to initiate a change in cell activity. Ends with regulation of a downstream cellular process, e.g. transcription. |
| | GO:0003051 | | angiotensin-mediated drinking behavior | | The drinking behavior that is mediated by the action of angiotensin in the brain. Angiotensin stimulates the brain centers that control thirst. |
| | GO:0014824 | | artery smooth muscle contraction | | A process in which force is generated within smooth muscle tissue, resulting in a change in muscle geometry. This process occurs in the artery. Force generation involves a chemo-mechanical energy conversion step that is carried out by the actin/myosin complex activity, which generates force through ATP hydrolysis. The artery is a vessel carrying blood away from the heart. |
| | GO:0035411 | | catenin import into nucleus | | The directed movement of a catenin protein from the cytoplasm into the nucleus. |
| | GO:0061049 | | cell growth involved in cardiac muscle cell development | | The growth of a cardiac muscle cell, where growth contributes to the progression of the cell over time from its initial formation to its mature state. |
| | GO:0007166 | | cell surface receptor signaling pathway | | A series of molecular signals initiated by activation of a receptor on the surface of a cell. The pathway begins with binding of an extracellular ligand to a cell surface receptor, or for receptors that signal in the absence of a ligand, by ligand-withdrawal or the activity of a constitutively active receptor. The pathway ends with regulation of a downstream cellular process, e.g. transcription. |
| | GO:0071260 | | cellular response to mechanical stimulus | | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a mechanical stimulus. |
| | GO:0006883 | | cellular sodium ion homeostasis | | Any process involved in the maintenance of an internal steady state of sodium ions at the level of a cell. |
| | GO:0050663 | | cytokine secretion | | The regulated release of cytokines from a cell. Cytokines are any of a group of proteins that function to control the survival, growth and differentiation of tissues and cells, and which have autocrine and paracrine activity. |
| | GO:0007565 | | female pregnancy | | The set of physiological processes that allow an embryo or foetus to develop within the body of a female animal. It covers the time from fertilization of a female ovum by a male spermatozoon until birth. |
| | GO:0048144 | | fibroblast proliferation | | The multiplication or reproduction of fibroblast cells, resulting in the expansion of the fibroblast population. |
| | GO:0001822 | | kidney development | | The process whose specific outcome is the progression of the kidney over time, from its formation to the mature structure. The kidney is an organ that filters the blood and/or excretes the end products of body metabolism in the form of urine. |
| | GO:0016525 | | negative regulation of angiogenesis | | Any process that stops, prevents, or reduces the frequency, rate or extent of angiogenesis. |
| | GO:0030308 | | negative regulation of cell growth | | Any process that stops, prevents, or reduces the frequency, rate, extent or direction of cell growth. |
| | GO:0010951 | | negative regulation of endopeptidase activity | | Any process that decreases the frequency, rate or extent of endopeptidase activity, the endohydrolysis of peptide bonds within proteins. |
| | GO:0051387 | | negative regulation of neurotrophin TRK receptor signaling pathway | | Any process that stops, prevents, or reduces the frequency, rate or extent of the neurotrophin TRK receptor signaling pathway. |
| | GO:0034104 | | negative regulation of tissue remodeling | | Any process that stops, prevents, or reduces the frequency, rate, or extent of tissue remodeling. |
| | GO:1905010 | | positive regulation of L-lysine import across plasma membrane | | Any process that activates or increases the frequency, rate or extent of L-lysine import into cell. |
| | GO:0045777 | | positive regulation of blood pressure | | Any process in which the force of blood traveling through the circulatory system is increased. |
| | GO:0090190 | | positive regulation of branching involved in ureteric bud morphogenesis | | Any process that increases the rate, frequency or extent of branching involved in ureteric bud morphogenesis, the process in which the branching structure of the ureteric bud is generated and organized. The ureteric bud is an epithelial tube that grows out from the metanephric duct. The bud elongates and branches to give rise to the ureter and kidney collecting tubules. |
| | GO:0010666 | | positive regulation of cardiac muscle cell apoptotic process | | Any process that increases the rate or extent of cardiac cell apoptotic process, a form of programmed cell death induced by external or internal signals that trigger the activity of proteolytic caspases whose actions dismantle a cardiac muscle cell and result in its death. |
| | GO:0010613 | | positive regulation of cardiac muscle hypertrophy | | Any process that increases the rate, frequency or extent of the enlargement or overgrowth of all or part of the heart due to an increase in size (not length) of individual cardiac muscle fibers, without cell division. |
| | GO:0043085 | | positive regulation of catalytic activity | | Any process that activates or increases the activity of an enzyme. |
| | GO:0008284 | | positive regulation of cell proliferation | | Any process that activates or increases the rate or extent of cell proliferation. |
| | GO:0032270 | | positive regulation of cellular protein metabolic process | | Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways involving a protein, occurring at the level of an individual cell. |
| | GO:0010873 | | positive regulation of cholesterol esterification | | Any process that increases the frequency, rate or extent of cholesterol esterification. Cholesterol esterification is the lipid modification process in which a sterol ester is formed by the combination of a carboxylic acid (often a fatty acid) and cholesterol. In the blood this process is associated with the conversion of free cholesterol into cholesteryl ester, which is then sequestered into the core of a lipoprotein particle. |
| | GO:0007204 | | positive regulation of cytosolic calcium ion concentration | | Any process that increases the concentration of calcium ions in the cytosol. |
| | GO:0010595 | | positive regulation of endothelial cell migration | | Any process that increases the rate, frequency, or extent of the orderly movement of an endothelial cell into the extracellular matrix to form an endothelium. |
| | GO:0045742 | | positive regulation of epidermal growth factor receptor signaling pathway | | Any process that activates or increases the frequency, rate or extent of epidermal growth factor receptor signaling pathway activity. |
| | GO:0003331 | | positive regulation of extracellular matrix constituent secretion | | Any process that increases the rate, frequency, or extent of the controlled release of molecules that form the extracellular matrix, including carbohydrates and glycoproteins by a cell or a group of cells. |
| | GO:2001238 | | positive regulation of extrinsic apoptotic signaling pathway | | Any process that activates or increases the frequency, rate or extent of extrinsic apoptotic signaling pathway. |
| | GO:0048146 | | positive regulation of fibroblast proliferation | | Any process that activates or increases the frequency, rate or extent of multiplication or reproduction of fibroblast cells. |
| | GO:1903598 | | positive regulation of gap junction assembly | | Any process that activates or increases the frequency, rate or extent of gap junction assembly. |
| | GO:2001275 | | positive regulation of glucose import in response to insulin stimulus | | Any process that activates or increases the frequency, rate or extent of glucose import in response to insulin stimulus. |
| | GO:1902632 | | positive regulation of membrane hyperpolarization | | Any process that activates or increases the frequency, rate or extent of membrane hyperpolarization. |
| | GO:0045429 | | positive regulation of nitric oxide biosynthetic process | | Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of nitric oxide. |
| | GO:0050731 | | positive regulation of peptidyl-tyrosine phosphorylation | | Any process that activates or increases the frequency, rate or extent of the phosphorylation of peptidyl-tyrosine. |
| | GO:0014068 | | positive regulation of phosphatidylinositol 3-kinase signaling | | Any process that activates or increases the frequency, rate or extent of signal transduction mediated by the phosphatidylinositol 3-kinase cascade. |
| | GO:0061098 | | positive regulation of protein tyrosine kinase activity | | Any process that increases the rate, frequency, or extent of protein tyrosine kinase activity. |
| | GO:0035815 | | positive regulation of renal sodium excretion | | Any process that increases the amount of sodium excreted in urine over a unit of time. |
| | GO:0032930 | | positive regulation of superoxide anion generation | | Any process that activates or increases the frequency, rate or extent of enzymatic generation of superoxide by a cell. |
| | GO:0045893 | | positive regulation of transcription, DNA-templated | | Any process that activates or increases the frequency, rate or extent of cellular DNA-templated transcription. |
| | GO:1904754 | | positive regulation of vascular associated smooth muscle cell migration | | Any process that activates or increases the frequency, rate or extent of vascular associated smooth muscle cell migration. |
| | GO:1904707 | | positive regulation of vascular smooth muscle cell proliferation | | Any process that activates or increases the frequency, rate or extent of vascular smooth muscle cell proliferation. |
| | GO:0042981 | | regulation of apoptotic process | | Any process that modulates the occurrence or rate of cell death by apoptotic process. |
| | GO:0008217 | | regulation of blood pressure | | Any process that modulates the force with which blood travels through the circulatory system. The process is controlled by a balance of processes that increase pressure and decrease pressure. |
| | GO:0050880 | | regulation of blood vessel size | | Any process that modulates the size of blood vessels. |
| | GO:0051924 | | regulation of calcium ion transport | | Any process that modulates the frequency, rate or extent of the directed movement of calcium ions into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore. |
| | GO:1903779 | | regulation of cardiac conduction | | Any process that modulates the frequency, rate or extent of cardiac conduction. |
| | GO:1901201 | | regulation of extracellular matrix assembly | | Any process that modulates the frequency, rate or extent of extracellular matrix assembly. |
| | GO:0002027 | | regulation of heart rate | | Any process that modulates the frequency or rate of heart contraction. |
| | GO:0048169 | | regulation of long-term neuronal synaptic plasticity | | A process that modulates long-term neuronal synaptic plasticity, the ability of neuronal synapses to change long-term as circumstances require. Long-term neuronal synaptic plasticity generally involves increase or decrease in actual synapse numbers. |
| | GO:0014061 | | regulation of norepinephrine secretion | | Any process that modulates the frequency, rate or extent of the regulated release of norepinephrine. |
| | GO:0035813 | | regulation of renal sodium excretion | | Any process that modulates the amount of sodium excreted in urine over a unit of time. |
| | GO:0003081 | | regulation of systemic arterial blood pressure by renin-angiotensin | | The process in which renin-angiotensin modulates the force with which blood passes through the circulatory system. |
| | GO:0051969 | | regulation of transmission of nerve impulse | | Any process that modulates the frequency, rate or extent of transmission of a nerve impulse, the sequential electrochemical polarization and depolarization that travels across the membrane of a neuron in response to stimulation. |
| | GO:0003014 | | renal system process | | A organ system process carried out by any of the organs or tissues of the renal system. The renal system maintains fluid balance, and contributes to electrolyte balance, acid/base balance, and disposal of nitrogenous waste products. In humans, the renal system comprises a pair of kidneys, a pair of ureters, urinary bladder, urethra, sphincter muscle and associated blood vessels; in other species, the renal system may comprise related structures (e.g., nephrocytes and malpighian tubules in Drosophila). |
| | GO:0002018 | | renin-angiotensin regulation of aldosterone production | | The process in which an increase in active angiotensin stimulates the adrenal cortices to secrete aldosterone. |
| | GO:0014873 | | response to muscle activity involved in regulation of muscle adaptation | | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a muscle activity stimulus. This process occurs as part of the regulation of muscle adaptation. |
| | GO:0048659 | | smooth muscle cell proliferation | | The multiplication or reproduction of smooth muscle cells, resulting in the expansion of a cell population. |
| | GO:0051403 | | stress-activated MAPK cascade | | A series of molecular signals in which a stress-activated MAP kinase cascade relays one or more of the signals; MAP kinase cascades involve at least three protein kinase activities and culminate in the phosphorylation and activation of a MAP kinase. |
| | GO:0070471 | | uterine smooth muscle contraction | | A process in which force is generated within smooth muscle tissue, resulting in a change in muscle geometry. This process occurs in the uterus. Force generation involves a chemo-mechanical energy conversion step that is carried out by the actin/myosin complex activity, which generates force through ATP hydrolysis. The uterus is a muscular organ of the female mammal for containing and usually for nourishing the young during development prior to birth. |
| | GO:0042310 | | vasoconstriction | | A decrease in the diameter of blood vessels, especially arteries, due to constriction of smooth muscle cells that line the vessels, and usually causing an increase in blood pressure. |
| | GO:0042311 | | vasodilation | | An increase in the internal diameter of blood vessels, especially arterioles or capillaries, due to relaxation of smooth muscle cells that line the vessels, and usually resulting in a decrease in blood pressure. |
| cellular component |
|---|
| | GO:0072562 | | blood microparticle | | A phospholipid microvesicle that is derived from any of several cell types, such as platelets, blood cells, endothelial cells, or others, and contains membrane receptors as well as other proteins characteristic of the parental cell. Microparticles are heterogeneous in size, and are characterized as microvesicles free of nucleic acids. |
| | GO:0005737 | | cytoplasm | | All of the contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures. |
| | GO:0070062 | | extracellular exosome | | A vesicle that is released into the extracellular region by fusion of the limiting endosomal membrane of a multivesicular body with the plasma membrane. Extracellular exosomes, also simply called exosomes, have a diameter of about 40-100 nm. |
| | GO:0005576 | | extracellular region | | The space external to the outermost structure of a cell. For cells without external protective or external encapsulating structures this refers to space outside of the plasma membrane. This term covers the host cell environment outside an intracellular parasite. |
| | GO:0005615 | | extracellular space | | That part of a multicellular organism outside the cells proper, usually taken to be outside the plasma membranes, and occupied by fluid. |
| | GO:0005739 | | mitochondrion | | A semiautonomous, self replicating organelle that occurs in varying numbers, shapes, and sizes in the cytoplasm of virtually all eukaryotic cells. It is notably the site of tissue respiration. |
Description
